Articles tagged "Liver grafts"

2021 American Transplant Congress
Predictive Factors of the Hepatic Artery Thrombosis in Liver Transplantation Through the Analysis of Donor Characteristics
M. M. Pascale¹, G. Moschetta², G. Bianco², F. Frongillo², E. Nure², F. Giovinazzo², S. Agnes²
¹General Surgery and Liver Transplant Unit, Fondazione, Roma, Italy, ²General Surgery and Liver Transplant Unit, Fondazione "Policlinico A. Gemelli" UCSC - Rome, Roma, Italy
*Purpose: Hepatic artery thrombosis (HAT) is one of the most severe complications after liver transplantation. It is treated as soon as possible to avoid irreversible…
2021 American Transplant Congress
Hepatic Artery Thrombosis and Liver Transplantation: Patient Management and Candidate Selection for Re-transplantation
H. Fernandez, A. Wall, A. Gupta, E. Martinez, J. Bayer, G. McKenna, N. Onaca, R. Ruiz, C. Spak, G. Testa
Baylor University Medical Center, Dallas, TX
*Purpose: Hepatic artery thrombosis (HAT) is a severe complication in liver transplantation (OLTX). Re-OLTX for patients with HAT has been met with controversy due to…
2021 American Transplant Congress
Changes in Liver Transplant Volume and Induction During the Covid-19 Era
T. Alhamad, J. Wellen, K. Lentine, M. Doyke, W. Chapman, Y. Al-Hosni, D. Axelrod, S. Chang
Washington University School of Medicine in St. Louis, Saint Louis, MO
*Purpose: The rapid spread and high infectivity of COVID-19 resulted in disruption of transplant procedures at many centers, including pauses in living donor transplantation and…
2021 American Transplant Congress
Can an Organ Survive for More Than 100 Years Between Donor and Recipient
R. Gruessner, J. Renz, A. C. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: It has been hypothesized that parenchymal grafts have a longer life expectancy than the cardio-cerebro-vascular system. We investigated the occurrence of deceased-donor liver (DDOLT),…
2021 American Transplant Congress
Liver Transplant in Adult Recipients Using Pediatric Deceased Donor Liver Grafts
P. Vargas¹, C. Argo², H. Zachary², M. Stotts², N. Intagliata², P. Northup², S. Pelletier¹, J. Oberholzer¹, N. Goldaracena¹
¹Transplant surgery, University of Virginia, Charlottesville, VA, ²Gastroenterology and Hepatology, University of Virginia, Charlottesville, VA
*Purpose: The aim of this study is to evaluate the outcomes following liver transplantation (LT) in adults using grafts from a pediatric deceased donor.*Methods: A…
2021 American Transplant Congress
Adult Deceased Donor Liver Transplantation with Split Liver Grafts vs Whole Liver Grafts. A Single-Center Experience
P. Vargas¹, C. Argo², H. Zachary², M. Stotts², N. Intagliata², P. Northup², S. Pelletier¹, J. Oberholzer¹, N. Goldaracena¹
¹Transplant Surgery, University of Virginia Health System, Charlottesville, VA, ²Gastroenterology and Hepatology, University of Virginia Health System, Charlottesville, VA
*Purpose: The present study aims to report outcomes of adults following SLT in a single-center and compare this selected group with adults recipients following whole…
2021 American Transplant Congress
Role of Recovering Surgeon in DCD Liver Transplant Outcomes
E. Macdonough, K. Pont, B. Aqel, K. Valenti, W. Hewitt, A. Moss, K. S. Reddy, C. Jadlowiec
Mayo Clinic, Phoenix, AZ
*Purpose: Donation after cardiac death (DCD) liver transplant (LT) outcomes have continued to improve. Variability in outcomes has been attributed to center and recovering surgeon…
2021 American Transplant Congress
Liver Transplant Outcomes Using Nationally Allocated Grafts
S. Ohara¹, B. Lizaola-Mayo², P. Morgan², D. Das³, J. Wagler⁴, K. S. Reddy², B. Aqel², A. Moss², C. Jadlowiec²
¹Valleywise Health General Surgery Residency Program, Phoenix, AZ, ²Mayo Clinic, Phoenix, AZ, ³Mayo Clinic Alix School of Medicine, Scottsdale, AZ, ⁴John C Lincoln, Phoenix, AZ
*Purpose: There is national variation in acceptance criteria and utilization of livers across transplant centers. Data pertaining to outcomes of liver grafts declined by local…
2021 American Transplant Congress
Incorporation of Donor Liver Macrovesicular Steatosis Into Srtr Risk Adjustment Models for Deceased Donor Yield and Post-Transplant Outcome
A. Kwong¹, C. Wang², A. Wey³, N. Salkowski³, J. Snyder⁴, J. Wetmore², A. Israni², J. Lake⁴, P. Stock⁵, W. Kim¹
¹Stanford University, Redwood City, CA, ²Medicine, Hennepin Healthcare, Minneapolis, MN, ³Scientific Registry of Transplant Recipients, Minneapolis, MN, ⁴University of Minnesota, Minneapolis, MN, ⁵University of California, San Francisco, San Francisco, CA
*Purpose: The SRTR had not traditionally included biopsy results in post-transplant risk adjustment, yet biopsy results may influence outcomes and thus decisions regarding organ acceptance.…
2021 American Transplant Congress
Assessing Liver Transplant Outcomes Utilizing Post-Cross Clamp Offers
K. Pont¹, E. Macdonough¹, D. Das², K. Valenti¹, P. Morgan¹, B. Aqel¹, A. Mathur¹, A. Moss¹, K. S. Reddy¹, C. Jadlowiec¹
¹Mayo Clinic, Phoenix, AZ, ²Mayo Clinic Alix School of Medicine, Scottsdale, AZ
*Purpose: With the ongoing organ shortage, there has been increased interest in utilizing post-cross clamp (XC) liver allografts as a means of expanding the donor…